Topics, Trends & Updates
December 2022
Dr. Asa Radix Receives the 30th Annual Linda Laubenstein Clinical Excellence Award
Congratulations Dr. Radix!

With the 30th annual Linda Laubenstein Clinical Excellence Award, the NYSDOH AIDS Institute recognizes a clinician for leadership and unwavering commitment to providing clinical care that has profoundly expanded awareness and access to HIV medicine and prevention in New York State. It is with great pleasure that the AIDS Institute recognizes Dr. Asa Radix as this year’s awardee.

Asa Radix, MD, PhD, FACP, FIDSA, is the Senior Director of Research and Education at the Callen-Lorde Community Health Center and a Clinical Associate Professor of Medicine at New York University.

Dr. Radix grew up in Grenada, West Indies, and attended university there before moving to the United States to complete an internal medicine residency and infectious diseases fellowship at the University of Connecticut.

After a decade working in the U.S., with brief interruptions to complete tropical medicine and public health training in the United Kingdom, Dr. Radix returned to the Dutch Caribbean to direct a public health department. While there, they implemented a range of services for people living with HIV, participated in the creation of the first regional antiretroviral guidelines, and served as the clinical lead for the WHO Expanded Program on Immunization and the Pan American Health Organization HIV/STI Technical Advisory Committee.

In 2006, Dr. Radix returned to the U.S. as the associate medical director at Callen-Lorde and continued to provide technical support to the Caribbean, working with organizations such as the Pan Caribbean Partnership Against HIV/AIDS and multiple NGOs to enhance PrEP uptake and improve access to treatment for people living with HIV.

In 2010, Dr. Radix created a research and education department at Callen-Lorde that prioritizes community-based participatory research and training of healthcare workers in LGBTQ+ health and HIV treatment and prevention. The department currently has a broad research portfolio, including HIV and STI prevention research along with several studies that focus on transgender medicine, such as the LEGACY Project, the first community-based cohort of transgender individuals in the U.S.

Dr. Radix started providing care to transgender and gender diverse people during residency, and this has been an important part of their clinical and research practice ever since. Dr. Radix has contributed to multiple national and international guidelines on transgender health and was co-chair of the recently published World Professional Association of Transgender Health (WPATH) Standards of Care version 8 working group.

Dr. Radix contributes to several U.S. HIV guidelines committees, including the New York State Department of Health AIDS Institute’s Medical Care Criteria Guideline Committee and the U.S. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. An important part of this work has been ensuring that the needs of transgender and gender diverse people are fully included in all guidance related to HIV treatment and care.

Dr. Radix has published more than 100 peer-reviewed articles, predominately on HIV prevention, LGBTQ+ health, and transgender medicine, and serves as an Associate Editor of Transgender Health and the International Journal of Transgender Health.
New Guideline: Second-Line ART After Treatment Failure
or for Regimen Simplification
Lead author: Joseph P. McGowan, MD, FACP, FIDSA

This new guideline provides information to assist clinicians in making evidence-based decisions to change antiretroviral therapy (ART) regimens and formulate second-line and subsequent ART regimens for optimal viral suppression in patients with HIV. Toward that end, the goals of this guideline are to:

  • Increase clinicians’ ability to recognize ART failure
  • Increase clinicians’ ability to effectively manage switching a patient’s initial or subsequent ART regimen when indicated to:
  • Improve viral suppression
  • Recognize and respond to virologic failure in a timely fashion
  • Improve tolerability
  • Reduce toxic effects
  • Avoid drug-drug interactions
  • Simplify (i.e., change from a multi-tablet regimen to a single-tablet regimen)
  • Ensure safety during pregnancy
  • Assist clinicians in managing a patient’s resumption of ART after a treatment interruption
  • Assist clinicians in recognizing cases that may benefit from expert consultation, such as when choosing a new ART regimen for a patient who has already been treated with multiple ART regimens or has other complicating factors
  • Encourage clinicians to seek the assistance of an experienced HIV care provider when treating patients with extensive resistance to antiretroviral drugs

Conversations With CEI Podcast
Taking the Next Step: Providing Proactive Reproductive Health Care in Your Clinical Setting: Reproductive healthcare is a critical part of healthcare overall. Yet components of this care, including abortion, are becoming more and more inaccessible to certain parts of the population, worsened by the overturning of Roe vs. Wade. The implications of this decision on access to care, marginalization, and inequity are already being seen and causing substantial concern within the medical community.

In this episode, Dr. Erica Bostick chats with Dr. Rachael Phelps, a nationally recognized family planning expert, about the impact of this decision on New York State clinicians and patients. Dr. Phelps offers her expertise and insights into what encompasses reproductive healthcare and how clinicians can “take the next step” in offering comprehensive, preventative reproductive health services to patients of all ages.

Hot Topics
Upcoming Training, Education, and Events
Are You a Subscriber?
If this newsletter was forwarded to you, please subscribe now to make sure you receive the Clinical Guidelines Program news every month and stay current with new and updated guidelines.

Subscribing is as easy as entering your email address. We will send you just 1 email per month, and we do not share our mailing list.
Please subscribe now!
Comment? Question? Suggestion? Drop us a line: We welcome feedback and suggestions, and if you send us a question, we will get back to you as quickly as possible. Please note, however, that we cannot answer questions about the care or treatment of specific patients and cannot provide clinical advice.